Elena Bekerman

Company: Gilead Sciences

Job title: Sr Research Scientist

Seminars:

Evaluation of an Oral TLR7 Agonist as Part of a Combination HIV Cure Strategy 1:30 pm

Vesatolimod (VES), an oral, selective TLR7 agonist TLR7 activation contributes to remission and/or cure in preclinical models for HIV Clinical development of VES for HIV cureRead more

day: Conference Day 2